Disease Overview：Antral gastritis（AG）
Antral gastritis is a chronic inflammatory condition localized to the antrum—the lower, funnel-shaped portion of the stomach—often resulting from Helicobacter pylori infection, long-term NSAID use, bile reflux, or autoimmune mechanisms. Patients commonly present with epigastric discomfort, early satiety, nausea, and occasionally hematemesis or melena in severe cases. Diagnosis relies on upper gastrointestinal endoscopy with targeted biopsies, histopathological assessment (including H. pylori staining), and adjunctive tests such as urea breath testing or stool antigen assays. Left untreated, antral gastritis may progress to atrophic gastritis, intestinal metaplasia, or increase gastric cancer risk—underscoring the importance of timely, evidence-based management involving eradication therapy, acid suppression (e.g., PPIs), mucosal protectants, and lifestyle modification.
China offers distinct advantages for international patients seeking high-quality care: its tertiary hospitals house nationally certified gastroenterology specialists with extensive experience in complex gastritis subtyping and refractory H. pylori eradication. Advanced endoscopic platforms—including high-definition narrow-band imaging (NBI) and confocal laser endomicroscopy—enable precise real-time mucosal assessment. Clinical outcomes are robust: over 92% H. pylori eradication rates in accredited centers, supported by longitudinal follow-up protocols. Treatment costs remain significantly lower than in the US, UK, or Germany—typically 40–60% less for comprehensive diagnostic workup and 12-week therapeutic regimens—without compromising clinical standards.
As a dedicated medical tourism agency, we streamline the patient journey: verifying hospital accreditation, coordinating specialist consultations, securing priority endoscopy slots, providing bilingual clinical liaisons, and delivering itemized, upfront pricing—all while offering end-to-end logistical support from visa assistance to post-treatment telehealth follow-up.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown for Antral Gastritis (Gastroenterology)
Non-Surgical / Conservative Management
*Target Criteria:* Mild-to-moderate symptoms (epigastric discomfort, bloating, early satiety), *H. pylori*–positive or negative, no ulceration, no bleeding, no dysplasia on endoscopy.
- •First-Line Pharmacotherapy (4–8 weeks)
- *PPI monotherapy (e.g., esomeprazole 20 mg OD):* $18–$32/month - *H2-receptor antagonist (e.g., famotidine 20 mg BD):* $8–$15/month - *Mucosal protectants (e.g., rebamipide 100 mg TID):* $24–$40/month
- •Diagnostic & Monitoring Fees (Per Episode)
- *H. pylori* testing (urea breath test): $22–$36 - Serum pepsinogen I/II + gastrin-17 (for atrophic risk stratification): $48–$65 - CBC, liver/kidney function panel: $26–$39
Surgical / Procedural Interventions
*Eligibility Criteria:* Refractory antral gastritis with severe atrophy/metaplasia, persistent bleeding unresponsive to medical therapy, or suspicion of early neoplastic change requiring resection.
- •Endoscopic Mucosal Resection (EMR) or Endoscopic Submucosal Dissection (ESD)
- Procedure fee (Grade 3A hospital, including anesthesia, histopathology, and overnight observation): $1,850–$2,650 - Preoperative workup (EKG, chest X-ray, coagulation panel, cardiac echo if >65 yrs): $110–$165
- •Surgical Resection (Rare; only for invasive carcinoma or massive refractory bleeding)
- Preoperative staging (abdominal CT + EUS): $280–$410
Special / Complex Condition Management
- •*Autoimmune antral gastritis with pernicious anemia:* Lifelong B12 IM injections ($12–$18/dose, q1–3 months) + annual endoscopy ($195–$275)
- •*NSAID-induced refractory antral inflammation:* COX-2 inhibitor switch + high-dose PPI + sucralfate — monthly cost $52–$88
- •*Chronic *H. pylori* recurrence (>2 failed regimens):* Culture-guided tailored therapy + rifabutin-based salvage — total course $135–$210
Quick Selection Guide
- •Young adult (<45), mild symptoms, budget-conscious: Start with *H. pylori* testing ($22) → PPI + mucosal protectant ($42/month). Total first-month outlay: ~$75.
- •Middle-aged (45–65), confirmed *H. pylori*, moderate symptoms: Quadruple therapy ($42) + endoscopy ($225) + 8-week PPI ($64). Total: ~$330.
- •Elderly (>65) with comorbidities (COPD, CKD) and persistent bleeding: Urgent endoscopy ($275) + EMR if dysplasia ($2,200) + pre-op workup ($150). Total: ~$2,625.
- •Atrophic/metaplastic antral gastritis (PG I <30 ng/mL, PG I/II ratio <3): Annual surveillance endoscopy ($225) + serum B12/folate monitoring ($32). Annual cost: ~$260.
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Antral gastritis Medical Vacation Packages
Curated transparent all-inclusive packages combining Antral gastritis treatment with China top medical destinations:
